Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$91.61
+2.4%
$83.21
$58.50
$98.43
$114.20B0.628.45 million shs7.58 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$49.06
+7.5%
$49.95
$22.28
$59.55
$18.11B1.057.38 million shs6.91 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
-1.11%-1.37%+9.23%+11.33%+41.04%
Moderna, Inc. stock logo
MRNA
Moderna
-0.91%-2.96%+0.60%-21.04%+68.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$91.61
+2.4%
$83.21
$58.50
$98.43
$114.20B0.628.45 million shs7.58 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$49.06
+7.5%
$49.95
$22.28
$59.55
$18.11B1.057.38 million shs6.91 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
-1.11%-1.37%+9.23%+11.33%+41.04%
Moderna, Inc. stock logo
MRNA
Moderna
-0.91%-2.96%+0.60%-21.04%+68.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.85
Moderate Buy$99.688.81% Upside
Moderna, Inc. stock logo
MRNA
Moderna
1.83
Reduce$35.73-27.16% Downside

Current Analyst Ratings Breakdown

Latest MRNA and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/1/2026
CVS Health Corporation stock logo
CVS
CVS Health
Reiterated RatingOverweight$113.00
6/1/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$102.00 ➝ $108.00
5/26/2026
Moderna, Inc. stock logo
MRNA
Moderna
Reiterated RatingNeutral
5/26/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$101.00 ➝ $106.00
5/20/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOutperform$102.00 ➝ $110.00
5/14/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$90.00 ➝ $104.00
5/14/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$93.00 ➝ $106.00
5/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$101.00 ➝ $111.00
5/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOutperform$94.00 ➝ $106.00
5/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$105.00 ➝ $110.00
5/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$105.00 ➝ $110.00
(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$402.07B0.29$15.24 per share6.01$59.38 per share1.54
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B10.01N/AN/A$22.14 per share2.22
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$2.2740.3610.960.880.72%11.88%3.54%7/30/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$8.15N/AN/AN/A-143.55%-26.64%-19.32%7/31/2026 (Estimated)

Latest MRNA and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
CVS Health Corporation stock logo
CVS
CVS Health
$2.21$2.57+$0.36$2.30$94.99 billion$100.43 billion
5/1/2026Q1 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$3.02-$3.40-$0.38-$3.40$236.37 million$389.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.662.90%+5.87%117.18%4 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest MRNA and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/18/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.37%4/23/20264/23/20265/4/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.78
0.87
0.66
Moderna, Inc. stock logo
MRNA
Moderna
0.08
2.41
2.35

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700396.79 million353.93 millionOptionable

Recent News About These Companies

Moderna to Present at Upcoming Conference in June 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVS Health stock logo

CVS Health NYSE:CVS

$91.61 +2.11 (+2.36%)
Closing price 03:58 PM Eastern
Extended Trading
$92.21 +0.60 (+0.66%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Moderna stock logo

Moderna NASDAQ:MRNA

$49.06 +3.42 (+7.49%)
Closing price 04:00 PM Eastern
Extended Trading
$48.72 -0.34 (-0.70%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.